IDL Diagnostics

0.35 SEK

+11.46%

Less than 1K followers

IDLDX

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for IDL Diagnostics

EV/S

Median 2019-2021

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)1.172.300.930.620.440.390.35
Shares40.277.1233.6230.4230.4230.4230.4
Market cap47.1177.2217.8142.8100.789.881.3
Enterprise value33.5135.2199.4----
EV/S75.61,609.016.6----
EV/EBITDAneg.neg.neg.----
EV/EBITneg.neg.neg.----
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B0.593.151.000.640.620.740.55
P/S106.42,109.118.23.92.31.61.5
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio88.0 %93.0 %95.6 %94.4 %93.6 %90.4 %83.8 %
Gearing ratio------8.9 %